FINANCIALS

ALNY Alnylam Pharmaceuticals Inc 1178670

Income Statement
Revenue	alny-20251231	2,248,243,000
Net Income	alny-20251231	-278,157,000
Profit Margin		-12.37%

Balance Sheet
Current Assets	3,295,285,000
Assets	4,239,983,000
Current Liabilities	1,186,272,000
Liabilities	4,172,895,000
Equity	67,088,000
Shares Out	133,428,000

Cash Flow Statement
Operating Cash Flow	-8,312,000
Investing Cash Flow	-116,840,000

Market Analysis
Market Cap	41,440,035,390
Price	310.58
BVPS	0.52
PB	483.41
EPS	2.33
PE	133.32
PS	4.16
FCF	-125,152,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view ALNY documents filed with the SEC.

ALNY Filings Clear

View A List of Tickers